ESOMEPRAZOLE MAGNESIUM - esomeprazole magnesium capsule, delayed release
Wal-Mart Stores, Inc.
----------
Active ingredient (in each capsule)
*Esomeprazole 20 mg
(Each delayed-release capsule corresponds to 21.75 mg esomeprazole magnesium dihydrate USP)
These may be signs of a serious condition. See your doctor.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
14-Day Course of Treatment
Repeated 14-Day Courses (if needed)
Other information
colloidal silicon dioxide, FD&C blue no.1, gelatin, hydroxypropyl cellulose, hypromellose, magnesium carbonate, magnesium oxide, methacrylic acid copolymer dispersion, mono and diglycerides, polysorbate 80, propylene glycol, shellac, sodium lauryl sulfate, strong ammonia solution, sugar spheres (which contains liquid glucose, starch (maize) and sucrose), talc, titanium dioxide, triethyl citrate and yellow iron oxide.
Questions or comments?
call 1-888-287-1915
DISTRIBUTED BY:
Walmart Inc.,
Bentonville, AR 72716
PRODUCT OF INDIA
TS/DRUGS/22/2009
equate™
NDC 49035-980-05
24 HOURS
Esomeprazole Magnesium
Delayed-Release Capsules USP, 20 mg*
Acid Reducer
Treats Frequent Heartburn
• May take 1 to 4 days for full effect
14 CAPSULES
One 14-day course
of treatment
SEE NEW WARNING INFORMATION
NDC 49035-980-05
equate™
Compare to Nexium® 24 HR active ingredient**
Esomeprazole Magnesium
Delayed-Release Capsules USP, 20 mg*
Acid Reducer
24 HOURS
Treats Frequent Heartburn
• May take 1 to 4 days for full effect
Actual Size
14 CAPSULES
One 14-day course of treatment
SEE NEW WARNING INFORMATION
NDC 49035-980-08
equate™
Compare to Nexium® 24 HR active ingredient**
Esomeprazole Magnesium
Delayed-Release Capsules USP, 20 mg*
Acid Reducer
24 HOURS
Treats Frequent Heartburn
• May take 1 to 4 days for full effect
Actual Size
28 CAPSULES
Two 14-day courses of treatment
ESOMEPRAZOLE MAGNESIUM
esomeprazole magnesium capsule, delayed release |
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Labeler - Wal-Mart Stores, Inc. (051957769) |
Registrant - Aurohealth LLC (078728447) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Aurobindo Pharma Limited | 650381903 | ANALYSIS(49035-980) , MANUFACTURE(49035-980) |